[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100616733":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":25,"responsibleParty":186,"collaborators":10,"id":188,"slug":189,"hasResults":190,"nctId":191,"briefTitle":192,"officialTitle":193,"acronym":194,"eligibilityCriteria":195,"healthyVolunteers":190,"sex":196,"minAge":197,"maxAge":10,"enrollmentInfo":198,"targetDuration":10,"studyType":201,"phases":10,"briefSummary":202,"conditions":203,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":205,"lastUpdatePostDateStruct":206,"startDateStruct":209,"completionDateStruct":211,"leadSponsor":213,"locationsCount":214},{"fullName":5,"class":6},"Janssen Research & Development, LLC","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"NMIBC Participants: Routine Clinical Practice Setting",null,"Participants with confirmed diagnosis of NMIBC and who have initiated first dose of TAR-200 in a real-world clinical setting, within 6 weeks prior to baseline visit\u002FStudy visit 1 will be observed for 24 months from the initiation of the first dose of TAR-200, or until the participant dies, is lost to follow-up, or withdraws consent in the study. No intervention will be administered as a part of this study.",[13],{"name":14,"affiliation":5,"role":15},"Janssen Research & Development, LLC Clinical Trial","STUDY_DIRECTOR",[17,22],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Study Contact","CONTACT","844-434-4210","Participate-In-This-Study1@its.jnj.com",{"name":23,"role":19,"phone":24,"phoneExt":10,"email":10},"Eliza M. Raymundo, MD, DMCC, FPUA, FPCS","1-669-800-7705",[26,40,50,60,66,76,86,96,106,116,126,136,146,156,166,176],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":10},"University of Alabama at Birmingham","RECRUITING","Birmingham","Alabama","35294","United States","US",{"type":35,"coordinates":36},"Point",[37,38],-86.80249,33.52066,{"lat":38,"lon":37},{"facility":41,"status":28,"city":42,"state":43,"zip":44,"country":32,"countryCode":33,"cosmosGeoPoint":45,"geoPoint":49,"contacts":10},"Arkansas Urology","Little Rock","Arkansas","72211",{"type":35,"coordinates":46},[47,48],-92.28959,34.74648,{"lat":48,"lon":47},{"facility":51,"status":28,"city":52,"state":53,"zip":54,"country":32,"countryCode":33,"cosmosGeoPoint":55,"geoPoint":59,"contacts":10},"USC Norris Comprehensive Cancer Center","Los Angeles","California","90033",{"type":35,"coordinates":56},[57,58],-118.24368,34.05223,{"lat":58,"lon":57},{"facility":61,"status":28,"city":52,"state":53,"zip":62,"country":32,"countryCode":33,"cosmosGeoPoint":63,"geoPoint":65,"contacts":10},"Cedars Sinai Medical Center","90048",{"type":35,"coordinates":64},[57,58],{"lat":58,"lon":57},{"facility":67,"status":28,"city":68,"state":69,"zip":70,"country":32,"countryCode":33,"cosmosGeoPoint":71,"geoPoint":75,"contacts":10},"Colorado Clinical Research","Lakewood","Colorado","80228",{"type":35,"coordinates":72},[73,74],-105.08137,39.70471,{"lat":74,"lon":73},{"facility":77,"status":28,"city":78,"state":79,"zip":80,"country":32,"countryCode":33,"cosmosGeoPoint":81,"geoPoint":85,"contacts":10},"Florida Urology Partners","Wimauma","Florida","33598",{"type":35,"coordinates":82},[83,84],-82.29898,27.71253,{"lat":84,"lon":83},{"facility":87,"status":28,"city":88,"state":89,"zip":90,"country":32,"countryCode":33,"cosmosGeoPoint":91,"geoPoint":95,"contacts":10},"Associated Urological Specialists","Chicago Ridge","Illinois","60415",{"type":35,"coordinates":92},[93,94],-87.77922,41.70142,{"lat":94,"lon":93},{"facility":97,"status":28,"city":98,"state":99,"zip":100,"country":32,"countryCode":33,"cosmosGeoPoint":101,"geoPoint":105,"contacts":10},"Indiana University Melvin and Bren Simon Cancer Center","Indianapolis","Indiana","46202",{"type":35,"coordinates":102},[103,104],-86.15804,39.76838,{"lat":104,"lon":103},{"facility":107,"status":28,"city":108,"state":109,"zip":110,"country":32,"countryCode":33,"cosmosGeoPoint":111,"geoPoint":115,"contacts":10},"Michigan Institute of Urology","Troy","Michigan","48084",{"type":35,"coordinates":112},[113,114],-83.14993,42.60559,{"lat":114,"lon":113},{"facility":117,"status":28,"city":118,"state":119,"zip":120,"country":32,"countryCode":33,"cosmosGeoPoint":121,"geoPoint":125,"contacts":10},"Specialty Clinical Research of St Louis","St Louis","Missouri","63141",{"type":35,"coordinates":122},[123,124],-90.19789,38.62727,{"lat":124,"lon":123},{"facility":127,"status":28,"city":128,"state":129,"zip":130,"country":32,"countryCode":33,"cosmosGeoPoint":131,"geoPoint":135,"contacts":10},"SUNY Upstate Med Univ","Syracuse","New York","13210",{"type":35,"coordinates":132},[133,134],-76.14742,43.04812,{"lat":134,"lon":133},{"facility":137,"status":28,"city":138,"state":139,"zip":140,"country":32,"countryCode":33,"cosmosGeoPoint":141,"geoPoint":145,"contacts":10},"Urology Specialists of the Carolinas PLLC Charlotte","Charlotte","North Carolina","28204",{"type":35,"coordinates":142},[143,144],-80.84313,35.22709,{"lat":144,"lon":143},{"facility":147,"status":28,"city":148,"state":149,"zip":150,"country":32,"countryCode":33,"cosmosGeoPoint":151,"geoPoint":155,"contacts":10},"Low Country Urology Clinics","North Charleston","South Carolina","29406",{"type":35,"coordinates":152},[153,154],-79.97481,32.85462,{"lat":154,"lon":153},{"facility":157,"status":28,"city":158,"state":159,"zip":160,"country":32,"countryCode":33,"cosmosGeoPoint":161,"geoPoint":165,"contacts":10},"Urology Specialists of South Dakota","Sioux Falls","South Dakota","57108",{"type":35,"coordinates":162},[163,164],-96.72796,43.54369,{"lat":164,"lon":163},{"facility":167,"status":28,"city":168,"state":169,"zip":170,"country":32,"countryCode":33,"cosmosGeoPoint":171,"geoPoint":175,"contacts":10},"UPNT Research Institute","Arlington","Texas","76017",{"type":35,"coordinates":172},[173,174],-97.10807,32.73569,{"lat":174,"lon":173},{"facility":177,"status":28,"city":178,"state":179,"zip":180,"country":32,"countryCode":33,"cosmosGeoPoint":181,"geoPoint":185,"contacts":10},"Spokane Urology","Spokane","Washington","99202",{"type":35,"coordinates":182},[183,184],-117.42908,47.65966,{"lat":184,"lon":183},{"type":187,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100616733","a-study-to-assess-real-world-use-and-outcomes-of-tar-200-for-participants-with-non-muscle-invasive-bladder-cancer-nmibc-in-the-united-states-100616733",false,"NCT07309445","A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States","A Multicenter, Prospective, Longitudinal Study to Assess Real-World Use and Outcomes After the Launch of TAR-200 for NMIBC in the US","Nova-sTAR","Inclusion criteria:\n\n* Has a confirmed diagnosis of NMIBC based on TURBT or cold cup biopsy\n* Initiated first dose of TAR-200 in a real-world setting within 6 weeks prior to baseline visit\u002FStudy visit 1\n* Participants with childbearing potential are required to adhere to contraceptive recommendations as specified in the approved product labeling for TAR-200. Additionally, participants should seek consultation with their physician for personalized contraceptive advice\n* Must provide informed consent as described in the protocol\n\nExclusion criteria:\n\n* Has any medical condition deemed by the health care practitioner (HCP) as contraindicated to receive TAR-200 treatment\n* Had previous treatment with TAR-200 discontinued prior to baseline visit\u002FStudy visit 1\n* Previously received TAR-200 intravesically as part of a clinical trial(s)\n* Previously received greater than (\\>) 2 doses\u002Fcycles of TAR-200 in the real-world setting\n* Currently participating in an interventional bladder cancer clinical trial","ALL","18 Years",{"count":199,"type":200},150,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to assess how well TAR-200 works in real-word by measuring the time taken from the first TAR-200 insertion to worsening of cancer or until the signs and symptoms of cancer occur again (disease-free survival) in participants with non-muscle invasive bladder cancer (NMIBC; an early-stage bladder cancer that is limited to the inner lining of bladder).",[204],"Non-Muscle Invasive Bladder Neoplasms","2026-07-30",{"date":207,"type":208},"2026-07-31","ACTUAL",{"date":210,"type":208},"2026-06-12",{"date":212,"type":200},"2029-10-09",{"name":5,"class":6},16]